CytoReason Launches AI Assistant for Drug Development
Tel Aviv's CytoReason launches LINA AI assistant for drug development at JP Morgan Healthcare Conference, speeding research with accurate, biology-grounded.




















Tel Aviv's CytoReason launches LINA AI assistant for drug development at JP Morgan Healthcare Conference, speeding research with accurate, biology-grounded.
Israeli AI firm CytoReason expands drug discovery partnership with Sanofi in a new multi-year agreement valued up to $16 million, marking its fifth commercial.